VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,648,000 | +5.0% | 109,700 | -8.1% | 0.00% | 0.0% |
| Q4 2020 | $1,569,000 | +32.6% | 119,431 | -2.5% | 0.00% | 0.0% |
| Q3 2020 | $1,183,000 | -13.3% | 122,514 | +2.8% | 0.00% | 0.0% |
| Q2 2020 | $1,364,000 | +13.9% | 119,214 | +3.1% | 0.00% | 0.0% |
| Q1 2020 | $1,198,000 | -61.6% | 115,676 | -39.2% | 0.00% | -66.7% |
| Q4 2019 | $3,121,000 | +243.3% | 190,176 | +177.7% | 0.00% | +200.0% |
| Q3 2019 | $909,000 | +13.9% | 68,476 | +21.0% | 0.00% | 0.0% |
| Q2 2019 | $798,000 | -21.8% | 56,614 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $1,020,000 | -41.7% | 55,414 | -17.3% | 0.00% | -50.0% |
| Q4 2018 | $1,750,000 | +16.7% | 66,985 | +2.5% | 0.00% | 0.0% |
| Q3 2018 | $1,500,000 | +31.2% | 65,372 | +9.0% | 0.00% | 0.0% |
| Q2 2018 | $1,143,000 | +7.8% | 59,993 | -4.6% | 0.00% | 0.0% |
| Q1 2018 | $1,060,000 | +14.0% | 62,898 | +2.8% | 0.00% | +100.0% |
| Q4 2017 | $930,000 | -15.1% | 61,172 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,095,000 | +12.8% | 61,172 | +2.6% | 0.00% | 0.0% |
| Q2 2017 | $971,000 | +20.8% | 59,600 | +3.8% | 0.00% | +100.0% |
| Q1 2017 | $804,000 | -20.7% | 57,400 | -9.7% | 0.00% | -50.0% |
| Q4 2016 | $1,014,000 | -8.5% | 63,600 | -4.5% | 0.00% | 0.0% |
| Q3 2016 | $1,108,000 | +39.4% | 66,600 | -6.2% | 0.00% | +100.0% |
| Q2 2016 | $795,000 | +37.1% | 71,000 | +2.3% | 0.00% | 0.0% |
| Q1 2016 | $580,000 | -15.5% | 69,400 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $686,000 | -17.4% | 73,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $831,000 | -11.1% | 73,700 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $935,000 | +6.4% | 73,700 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $879,000 | 0.0% | 73,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $879,000 | +14.9% | 73,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $765,000 | -41.8% | 73,700 | -9.2% | 0.00% | -50.0% |
| Q2 2014 | $1,314,000 | +19.1% | 81,200 | +10.2% | 0.00% | 0.0% |
| Q1 2014 | $1,103,000 | +22.6% | 73,700 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $900,000 | +9.4% | 73,700 | -1.7% | 0.00% | -50.0% |
| Q3 2013 | $823,000 | +35.8% | 75,000 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $606,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |